Intravascular ultrasound (IVUS) developer Volcano of San Diego has placed more than 1,000 s5 and s5i devices in hospitals and other healthcare facilities in the past 12 months.
Volcano president and CEO Scott Huennekens credited clinical evidence for intravascular assessment as the primary reason for the technology's growth.
Recent data from international multicenter studies show the potential for limitations using angiography alone, as well as the clinical and economic benefits of using guidance with IVUS.
Related Reading
Siemens signs deal with Volcano, August 25, 2009
Volcano adds to revenue in 2008, February 18, 2009
Volcano wraps up Axsun buy, January 8, 2009
Volcano to acquire Axsun, January 6, 2009
Volcano launches new products, October 16, 2008
Copyright © 2009 AuntMinnie.com